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ABSTRACT 
The p, 6, and K opioid receptors are the three main types of opioid receptors found in the 
central nervous system (CNS) and periphery. These receptors and the peptides with which they 
interact are important in a number of physiological functions, including analgesia, respiration, 
and hormonal regulation. This study examines the expression of p, 6, and K receptor mRNAs in 
the rat brain and spinal cord using in situ hybridization techniques. Tissue sections were 
hybridized with 35S-labeled cRNA probes to the rat IJ. (744-1,064 b), 6 (304-1,287 b), and K 
(1,351-2,124 b) receptors. Each mRNA demonstrates a distinct anatomical distribution that 
corresponds well to known receptor binding distributions. Cells expressing p receptor mRNA 
are localized in such regions as the olfactory bulb, caudate-putamen, nucleus accumbens, 
lateral and medial septum, diagonal band of Broca, bed nucleus of the stria terminalis, most 
thalamic nuclei, hippocampus, amygdala, medial preoptic area, superior and inferior colliculi, 
central gray, dorsal and median raphe, raphe magnus, locus coeruleus, parabrachial nucleus, 
pontine and medullary reticular nuclei, nucleus ambiguus, nucleus of the solitary tract, nucleus 
gracilis and cuneatus, dorsal motor nucleus of vagus, spinal cord, and dorsal root ganglia. 
Cellular localization of 6 receptor mRNA varied from p or K, with expression in such regions as 
the olfactory bulb, allo- and neocortex, caudate-putamen, nucleus accumbens, olfactory 
tubercle, ventromedial hypothalamus, hippocampus, amygdala, red nucleus, pontine nuclei, 
reticulotegmental nucleus, motor and spinal trigeminal, linear nucleus of the medulla, lateral 
reticular nucleus, spinal cord, and dorsal root ganglia. Cells expressing K receptor mRNA 
demonstrate a third pattern of expression, with cells localized in regions such as the claustrum, 
endopiriform nucleus, nucleus accumbens, olfactory tubercle, medial preoptic area, bed nucleus 
of the stria terminalis, amygdala, most hypothalamic nuclei, median eminence, infundibulum, 
substantia nigra, ventral tegmental area, raphe nuclei, paratrigeminal and spinal trigeminal, 
nucleus of the solitary tract, spinal cord, and dorsal root ganglia. These findings are discussed in 
relation to the physiological functions associated with the opioid receptors. D 1% Wiley-Liss, Inc. 
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Several lines of research have demonstrated that the 
opioid receptors can be classified into three main types 
referred to as mu (p), delta (61, and kappa (K; Martin et al., 
1976; Lord et al., 1977; Chang and Cuatrecasas, 1979; 
Smith and Simon, 1980). The IJ. and K receptor types were 
initially differentiated by Martin and colleagues (1976) in 
the chronic spinal dog preparation and are the sites at  
which alkaloids, such as morphine, and benzomorphans, 
such as ethylketazocine, bind to produce their respective 
physiological effects. The 6 receptors, named for the mouse 
vas deferens preparation from which they were initially 
described (Lord et al., 1977), differ from the p and K binding 
sites and have a higher affinity for proenkephalin-derived 
peptides. These early studies suggesting multiple opioid 
receptor types have been extended by numerous anatomi- 
cal, pharmacological, biochemical, and behavioral studies 
(Gillan and Kosterlitz, 1982; Magnun et al., 1982; Wood, 
1982; Pasternak et al., 1983; Goldstein and James, 1984; 
James and Goldstein, 1984; Zukin and Zukin, 1984; McLean 
et al., 1986; Mansour et al., 1987; Goldstein and Naidu, 
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1989; Sharif and Hughes, 1989) demonstrating distinct 
opioid receptor types in the central nervous system (CNS) 
and periphery and have led to the cloning of at least three 
opioid receptor cDNAs that correspond to the pharmacologi- 
cally defined p, 6 ,  and K receptors (Evans et al., 1992; 
Kieffer et al., 1992; Chen et al., 1993; Fukada et al., 1993; 
Meng et al., 1993; Thompson et al., 1993; Wang et al., 1993; 
Yasuda et al., 1993). 
The three cloned opioid receptors are members of the 
seven transmembrane superfamily of G-protein coupled 
receptors and are homologous to one another at  both the 
amino acid and the nucleic acid levels, particularly in 
regions spanning the putative transmembrane domains 
and cytosolic loops. The most divergent regions of these 
receptors are the N- and C-termini, extracellular loops 2 
and 3, and transmembrane 4 (Chen et al., 1993; Fukada et 
al., 1993; Meng et al., 1993; Thompson et al., 1993; Wang et 
al., 1993; Yasuda et al., 1993). Northern blot analysis 
suggests that the opioid receptors are encoded by compar- 
atively large mRNAs that range from 4.5-11 kb for the rat 6 
receptor (Fukada et al., 1993) to 10-16 kb for the rat p 
receptor (Fukada et al., 1993; Thompson et al., 1993; Wang 
et al., 1993). The mouse K receptor appears to be encoded by 
a single mRNA transcript that is 5.2 kb in length (Yasuda et 
al., 1993). The relatively large size of opioid receptor 
mRNAs is primarily due to their long 3’-untranslated 
regions; the protein-coding and 5‘-untranslated regions 
range from 1.2-1.5 kb. 
Single genes have been suggested for the p,  6, and K 
receptors (Evans et al., 1992; Thompson et al., 1993; 
Yasuda et al., 1993). These genes contain multiple introns 
that may result in the transcription of alternatively spliced 
mRNA forms of each receptor type. The function of these 
long 3’-untranslated regions and the multiple mRNA tran- 
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scripts that are possible from a single receptor gene are 
presently unknown. 
The focus of this study is to compare the anatomical 
localization of the p, 6, and K receptor mRNAs in the rat 
CNS using in situ hybridization techniques. Previous stud- 
ies examining the distribution of p and K receptor mRNAs 
in the rat (Mansour et al., 1994a,b) and 6 receptor mRNA in 
the mouse (Mansour et al., 1993) have compared opioid 
receptor mRNA and receptor binding. The emphasis here is 
comparison of all three receptor mRNAs simultaneously in 
the rat CNS to gain further insights into their specific 
receptor distributions and their diverse functions. This 
analysis also provides the first anatomical description of 6 
receptor mRNA expression in the rat CNS. 
MATERIALS AND METHODS 
Tissue preparation 
Adult Sprague-Dawley rats (Charles River; n = 3, 250- 
300 g) were humanely killed by decapitation, and their 
brains were removed, frozen in liquid isopentane (-30°C) 
for 30 seconds, and transferred to dry ice. In addition to 
whole rat brains, a thoracic portion (1.5 cm) of spinal cord 
with attached dorsal roots and dorsal root ganglia was 
dissected and similarly frozen. Brain and spinal cord tissue 
were stored at -80°C until sectioning on a Bright cryostat 
(15 pm). The sections were thaw mounted on polylysine- 
subbed microscope slides and stored at  -80°C. 
In situ hybridization 
Adjacent series of frozen brain and spinal cord sections 
were removed from storage at -80°C and placed into 4% 
formaldehyde for 60 minutes (22OC) prior to processing for 
in situ hybridization (Mansour et al., 1993). Following 
three 5 minute rinses in 2~ SSC (300 mM sodium chloride, 
30 mM sodium citrate, pH 7.2), sections were treated with 
proteinase K (1 pg/ml in 100 mM Tris, pH 8.0, 50 mM 
EDTA) for 10 minutes at  37°C. Slides were then rinsed in 
water followed by 0.1 M triethanolamine, pH 8.0, and 
treated with a mixture of 0.1 M triethanolamine, pH 8.0, 
and acetic anhydride (400:1, vol/vol) for 10 minutes. The 
sections were rinsed again in water, dehydrated through 
graded alcohols, and allowed to air dry. 
Brain and spinal cord sections were hybridized with 
35S-UTP-and 35S-CTP-labeled riboprobes generated either 
to the rat p, 6, or K receptors. A polymerase chain reaction 
(PCR) fragment that corresponded to the transmembrane 
111-VI (744-1,064 b; Thompson et al., 1993) of the p 
receptor was used to prepare a cRNA probe. A cDNA 
fragment spanning from extracellular loop 1 to transmem- 
brane domain VII of the rat 6 receptor (304-1287 b; Fukuda 
et al., 1993) and a fragment corresponding to 45 bp of the 
terminal coding region and the 3'-untranslated region of 
the rat K receptor (1,351-2,124 b; Meng et al., 1993) were 
similarly cloned in Bluescript transcriptional vectors and 
used in preparing cRNA probes to the 6 and K receptors, 
respectively. The cRNA probes were diluted in hybridiza- 
tion buffer (75% formamide, 10% dextran sulfate, 3~ SSC, 
50 mM Na2P04, pH 7.4, l x  Denhardt's, 0.1 mgiml yeast 
tRNA, 10 mM dithiothreitol) to result in a final concentra- 
tion of 1-2 x lo6 cpmi50 pl. Volumes of 50 p1 of diluted 
probe were applied to coronal brain and spinal cord sec- 
tions. Glass coverslips were placed over sections to keep 
hybridization buffer in contact with tissue. The slides were 
then transferred to sealed humidifying chambers contain- 
ing 50% formamide and hybridized overnight at  55°C. 
The next day, the slides were rinsed in 2 x  SSC (5 
minutes) and treated with RNase A (200 pg/ml in 100 mM 
Tris, pH 8.0, and 0.5 M NaCl) for 60 minutes at  37°C. 
Subsequently, the sections were rinsed in 2~ SSC for 5 
minutes (22°C) and 0 . 1 ~  SSC for 60 minutes (65°C). 
Following the low-salt wash, sections were rinsed in water, 
dehydrated through graded alcohols, and air dried. Sections 
were apposed to Kodak XAR-5 X-ray film for 7 (S), 10 (p), or 
11 (K) days and dipped in NTBB film emulsion. Brain 
sections used to visualize IJ. and K receptor mRNAs were 
developed following a 35-day exposure to NTB2 emulsion, 
whereas those used for localizing 6 receptor mRNA in the 
brain were exposed for 24 days. Sections used to visualize 
the opioid receptor mRNAs in the spinal cord and dorsal 
root ganglia were developed following an 8 (p)-, 11 (K)-, or 
15 ($)-day exposure. Exposure times were chosen to maxi- 
mize the detection of specific in situ hybridization grains 
and were empirically determined by the periodic develop- 
ment of test slides. Following development of the NTBB 
film emulsion, all slides were washed in running water (30 
minutes, 22°C) and Nissl counterstained. 
RESULTS 
The following in situ hybridization results demonstrate 
that cells expressing p, 6, or K opioid receptor mRNA are 
differentially distributed in the rat brain and spinal cord. 
Each mRNA has a distinct anatomical distribution that 
corresponds well to known receptor binding distributions 
described with receptor autoradiography. p Receptor mRNA 
expression is widespread and localized in such regions as 
the striatal patches of the caudate-putamen, hippocampus, 
several thalamic nuclei, amygdala, locus coeruleus, parabra- 
chial nucleus, and the nucleus of the solitary tract. In 
contrast, cells expressing 6 receptor mRNA are found in 
such regions as the neocortex, pontine nuclei, caudate- 
putamen and nucleus accumbens, ventromedial hypothala- 
mus, hippocampus, amygdala, and linear nucleus of the 
medulla. Cells expressing K receptor mRNA demonstrate a 
third distribution predominantly localized in midline and 
ventral structures, including the claustrum, endopiriform 
nucleus, nucleus accumbens, olfactory tubercle, hypothala- 
mus, median eminence, paraventricular thalamus, substan- 
tia nigra, ventral tegmental area, and nucleus of the 
solitary tract. 
The anatomical results are organized as low-magnifica- 
tion darkfield micrographs (Figs. 1-1 1) illustrating the 
general distributions of the p, 6, and K receptor mRNAs in 
the rat brain. Figures 12-20 provide high-resolution cellu- 
lar images of p, 6, and K receptor mRNAs in selected brain 
and spinal cord regions using emulsion-dip autoradiogra- 
phy. Given that cRNA transcript lengths and exposure 
times vary somewhat with receptor type, the anatomical 
description provided is qualitative, and any reference to 
mRNA expression level applies within a particular receptor 
mRNA distribution, without implying quantitation across 
receptors. The anatomical nomenclature is that of Paxinos 
and Watson (1982). 
Telencephalon 
The distribution of cells expressing p, 6, and K receptor 
mRNAs are easily differentiated within the layers of the 
olfactory bulb. High levels of p receptor mRNA expression 
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Fig. 1. Darkfield autoradiograms comparing the I*, 6, and K receptor 
mRNA distributions in the rat olfactory bulb. Cells expressing p 
receptor mRNA are localized in the internal granular layer, mitral cell 
layer, and glomerular cell layer. High levels of 6 receptor mRNAare also 
are observed in the densely packed cells of the internal 
granular layer, in the cells of the mitral cell layer, and in 
scattered cells of the glomerular layer (Fig. 1, left). High 
levels of 6 receptor mRNA expression are also observed in 
the cells of the internal granular and mitral cell layers, but 
little if any 6 receptor mRNA expression is observed in the 
cells of the glomerular layer (Fig. 1, center). In contrast to 
the high numbers of cells expressing p and 6 receptor 
mRNAs in the olfactory bulb, only a few widely scattered 
cells in the internal granular layer express relatively high 
levels of K receptor mRNA, with no cells detected in the 
mitral or glomerular layers (Fig. 1, right). 
In addition to the main olfactory bulb, cells of the 
accessory olfactory bulb express high levels of p, receptor 
mRNA, with no detectable 6 or K receptor mRNA expres- 
sion. Regions such as the bed nucleus of the accessory 
olfactory tract and posterior mediocortical amygdala that 
have direct reciprocal projections to the accessory olfactory 
bulb also display high levels of p receptor mRNA expres- 
sion, further emphasizing the importance of p receptors in 
the processing of olfactory information. 
Cells of the anterior olfactory nucleus express p, 6, and K 
receptor mRNAs; however, their distributions differ with 
nuclear subdivisions. In the dorsal, ventral, medial, and 
lateral anterior olfactory nucleus, p receptor mRNA expres- 
sion is low, with comparatively few cells observed scattered 
in these nuclei (Fig. 2, top). More caudally, however, in the 
external and posterior divisions of the anterior olfactory 
nucleus, high levels of p. receptor expression are observed. 
In contrast, 6 receptor expression is high in most of the 
divisions of the anterior olfactory nucleus including the 
dorsal, medial, lateral, ventral, and posterior divisions (Fig. 
2,  center). Cells expressing K receptor mRNA show a high 
level of expression, predominantly in the dorsal and lateral 
anterior olfactory nucleus, with comparatively few cells 
detected in the medial, ventral, and posterior divisions (Fig. 
2, bottom). 
localized in the internal granular and mitral cell layers, but none can be 
detected in the glomerular cell layer. A few cells expressing K receptor 
mRNA are scattered in the internal granular cell layer. Scale bar = 
1,000 km. 
In neocortical and allocortical regions, cells expressing 6 
receptor mRNA are particularly prominent, with high 
levels of expression in the agranular insular, lateral orbital, 
prefrontal, cingulate, piriform, entorhinal, frontal, parietal, 
occipital, and temporal cortices. Generally, cells expressing 
6 receptor mRNA show a bilaminar distribution in neocorti- 
cal areas, with highest levels of expression in layers 2 , 3  and 
5 ,  6 (Figs. 2-8, center). A third peak of 6 receptor mRNA 
expression is seen in a thin layer of cells located in the 
deepest portion of layer 6 of most neocortical areas. Allocor- 
tical areas also show specific laminar expression patterns 
with high levels of expression, for example, in the piriform 
cortex localized in the densely packed cellular layer. $imi- 
larly, in the prefrontal cortex, 6 receptor expression is 
highest in layers 2 and 5 and the superficial portion of 
layer 6. 
In contrast, cells expressing p receptors show compar- 
atively low levels of expression in most neocortical and 
allocortical areas. Within the frontal, parietal, occipital, and 
temporal cortices, cells expressing p receptors are scattered 
in layers 2 and 3, with a moderate level of expression in cells 
found in the deepest portion of layer 6 immediately adjacent 
to the corpus callosum. Differences in laminar distributions 
are also observed in allocortical regions and often demon- 
strate a complementary pattern of expression compared to 
cells expressing 6 receptor mRNA. For example, in the 
piriform cortex, cells expressing p receptors are localized in 
a layer of cells superficial to those expressing 6. Similarly, in 
the prefrontal cortex, cells expressing p receptor mRNA are 
localized in a thin column of cells in layer 2 and in cells 
deeper to those expressing 6 in layer 6. Other allocortical 
areas expressing p receptor mRNA include the agranular 
insular and lateral orbital cortex, where cells have a scat- 
tered distribution and expression levels are low (Fig. 2, top). 
Cells expressing K receptor mRNA show yet a third 
pattern of expression in the neo- and allocortex. High levels 
of K receptor mRNA expression are observed in the lateral 
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Fig. 2. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression in the rostral cortex and the anterior olfactory 
nucleus. Cells expressing 6 receptor mRNA are localized in the piriform, 
cingulate, frontal, agranular insular, and lateral orbital cortices as well 
as the medial, dorsal, ventral, and lateral divisions of the anterior 
olfactory nucleus. Cells expressing K receptor mRNA have a more 
restricted distribution at this level and are localized predominantly in 
the lateral orbital and agranular insular cortices and in the dorsal and 
lateral divisions of the anterior olfactory nucleus. Scattered cells 
expressing p receptor mRNA are observed in frontal cortex and in the 
dorsal, ventral, medial, and lateral divisions of the anterior olfactory 
nucleus. Low levels of p receptor mRNA expression are also detected in 
the piriform and cingulate cortices. Scale bar = 1,000 pm. 
orbital cortex, with cells fanning out into the agranular 
insular cortex (Fig. 2,  bottom). In contrast to and 6 
receptor distributions, no K receptor mRNA can be detected 
in the piriform and prefrontal cortices, but high levels are 
seen in the entorhinal cortex (Figs. 2, 8, bottom). Within 
neocortical regions, cells expressing K receptor mRNA are 
localized in layers 5 and 6 of the parietal, temporal, and 
Fig. 3. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression at the level of the striatum. Cells expressing I.L 
receptor mRNA are localized in patches in the caudate-putamen and 
nucleus accumbens, in a layer of cells medial to the corpus callosum 
referred to as the subcallosal streak (arrowheads), the diagonal band of 
Broca, and the medial septum. Cells expressing 6 receptor mRNA have a 
more homogeneous distribution in the caudate-putamen and nucleus 
accumbens, with a higher number of cells expressing 6 receptor mRNA 
observed in the lateral caudate-putamen. In addition, individual large 
cells in the CPu demonstrate particularly high levels of 6 receptor 
mRNA. Cells expressing F receptor mRNA are also localized in the 
cingulate cortex, frontal and parietal cortices, endopiriform nucleus, 
claustrum, and olfactory tubercle. In contrast to the p and 6 receptor 
mRNA distributions, cells expressing K receptor mRNA are localized in 
the medial and ventral CPu, avoiding the lateral portion of the nucleus. 
K Receptor mRNA expression is also found in the endopiriform, 
claustrum, olfactory tubercle, diagonal band of Broca, and lateral 
septum. Higher resolution images of the cells expressing p, 6, and K 
receptor mRNAs in the striatum are provided in Figure 13. Scale bar = 
1,000 pm. 
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Fig. 4. Darkfield autoradiograms comparing I*., 6 ,  and K mRNA 
expression at the level of the crossing of the anterior commissure. Cells 
expressing I*. receptor mRNA are localized in the patches of caudate- 
putamen, medial preoptic area, ventral pallidum, lateral septum, and 
the septohypothalamic nucleus. At this level, cells expressing K receptor 
mRNA in the MPA are localized more medially compared to the more 
widespread distribution of cells expressing IJ. receptor mRNA. Other 
regions expressing K receptor mRNA include the ventral portion of 
parietal cortex, claustrum, endopiriform, ventral pallidum, olfactory 
tubercle, lateral septum, bed nucleus stria terminalis, and parastrial 
nucleus. In contrast, cells expressing 6 receptor mRNA are localized in 
the cingulate, parietal cortex, and in the caudate-putamen. Scale bar = 
1,000 Lm. 
occipital cortices. Few, if any, cells expressing K receptors 
are detected in the frontal cortex. Surprisingly, cells in the 
parietal, temporal, and occipital cortices expressing K recep- 
tors are localized only in the ventral extents of layers 5 and 
6 (Figs. 4-7, bottom) and do not extend dorsally as observed 
with most receptors found in the neocortex, including 
and 6. 
In the dorsal hippocampus and dentate gyrus, only p and 
6 receptor mRNA expression is observed. Cells expressing 6 
receptor mRNA are localized predominantly in the pyrami- 
dal cell layer, with occasional cells observed in the stratum 
oriens (Figs. 5-7, center). In addition to the expression of 6 
receptor mRNA within most pyramidal cells, scattered cells 
within the CA1-CA3 pyramidal layer express particularly 
high levels of 6 receptor mRNA. A few isolated cells in the 
pyramidal layer expressing high levels of 6 receptor mRNA 
are presented in Figure 12B. It  is unclear whether these 
high-expressing cells are pyramidal cells or interneurons. 
High levels of 6 receptor mRNA are also found in the 
dentate gyrus (Figs. 5-7, center), with expression localized 
in the granule cell layer. 
In contrast to the relatively large number of cells in the 
hippocampus and dentate gyms expressing 6 receptor 
mRNA, far fewer cells express p receptor mRNA in these 
regions. These cells are large, express relatively high levels 
of p receptor mRNA, and are scattered predominantly in 
the pyramidal cell layer, with occasional cells observed in 
stratum oriens and radiatum (Fig. 12A) of the hippocam- 
pus. Similarly, in the dentate gyrus, cells expressing p 
receptor mRNA are scattered in the granular cell layer and 
have a high level of expression. Rostral-caudal differences 
are observed with higher levels of p and 6 receptor observed 
in the caudal or temporal hippocampus and dentate gyms. K 
Receptor mRNA expression is also observed in the temporal 
hippocampus, with expression localized in the stratum 
radiatum. 
Cells expressing p and 6 mRNAs have a scattered distri- 
bution in the subiculum, with high levels of expression 
observed (Figs. 6,7). In contrast, only a low level of K mRNA 
expression is detected in the subiculum, with a few scat- 
tered, high-expressing cells observed. In other divisions of 
the subicular complex, however, such as the parasubicu- 
lum, cells express predominantly K receptor mRNA, with 
little p and 6 expression. Similarly, in the presubiculum, a 
selective expression of p receptor mRNA is observed, with 
little if any 6 or K receptor mRNA detected (Fig. 7). 
In the amygdala, cells expressing p, 6, or K receptor 
mRNA are differentially localized within nuclear groups. 
High levels of p receptor mRNA expression are found in the 
intercalated nuclei of the basolateral amygdala (Fig. 1 2 0 ,  
the posterior portion of the medial amygdala, and the 
posterior medial cortical amygdala (Fig. 6, top). Moderate 
levels of p receptor mRNA expression are found in the 
medial, basomedial, and centromedial nuclei, with low 
levels of expression in the anterior, basolateral, and ante- 
rior cortical amygdaloid nuclei. In contrast, the pattern of 6 
receptor mRNA expression differs with the highest levels of 
6 receptor mRNA in the lateral, basolateral, medial, and 
basomedial nuclei (Figs. 5 ,  center; 12D), with moderate 
levels in the posterior medial cortical nucleus. Yet a third 
pattern is observed with those cells expressing K receptor 
mRNA, with high levels in the central lateral, basolateral, 
and medial nuclei (Figs. 5, bottom; 12E,F). Particularly 
high levels of K receptor mRNA expression are also observed 
in the posterior portion of the medial nucleus and the 
posteromedial amygdalohippocampal transition area (Fig. 
6, bottom). High levels of K receptor mRNA expression are 
also observed in the nucleus of the lateral olfactory tract, 
which is thought to be a part of the extended amygdala 
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Fig. 5. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression at  the level of the diencephalon. High levels of p 
receptor mRNA expression are observed in several thalamic nuclei, 
including the medial habenula, laterodorsal, paraventricular, centrome- 
dial, and reuniens nuclei. In contrast, little 6 receptor mRNA expres- 
sion is observed in the nuclei of the thalamus, and K receptor mRNA 
expression is limited to such nuclei as the paraventricular and to the 
zona incerta. Within the hypothalamus, cells expressing K receptor are 
prominent in several nuclei, including the dorsomedial and ventrome- 
dial, whereas those expressing 6 receptor mRNA are restricted to the 
ventromedial nucleus. For higher resolution cellular images of cells 
expressing K receptor mRNA in other hypothalamic nuclei, see Figure 
14. Although no K receptor mRNA can be detected in the dorsal 
hippocampus and dentate gyrus, cells expressing p and 6 receptor 
mRNAs are observed. Cells expressing K receptor mRNA are promi- 
nent, however, in the amygdaloid nuclei, where K receptor mRNA 
expression is observed in the medial, basolateral, and central nuclei. 
High levels of 6 receptor mRNA expression are also observed in the 
basolateral, basomedial, and medial nuclei of the amygdala. Higher 
resolution images of cells expressing IJ., 6, and K receptor mRNA in the 
hippocampus and amygdaloid nuclei are provided in Figure 12. Scale 
bar = 1,000 Fm. 
involved in processing olfactory information. Somewhat 
lower levels of K receptor mRNA expression are observed in 
the centromedial and basomedial nuclei. 
The cells of the bed nucleus stria terminalis, also thought 
to be part of the extended amygdala, express k, 6, and K 
receptor mRNAs. Whereas p,, 6, and K receptor mRNA 
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Fig. 6. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression at  the level of the midbrain. Cells expressing K 
receptor mRNA are localized in the substantia nigra (pars compacta 
and pars reticulata), ventral tegmental area, posteromedial amygdalo- 
hippocampal area, central gray, superior colliculus, and temporal and 
occipital cortices. In contrast, only scattered cells in the substantia 
nigra, pars compacta, and VTA express p and 6 receptor mRNAs. 
Although they cannot be seen in these low-magnification autoradio- 
grams, cells expressing p and 6 receptor mRNAs are also localized in the 
substantia nigra, pars reticulata (see Fig. 15). Cells expressing 6 
receptor mRNA are prominent, however, in the pyramidal hippocampal 
fields, dentate gyrus, entorhinal, and temporal and occipital cortices as 
well as the subiculum. p Receptor mRNA expression is high in the 
posteromedial cortical amygdala, in the medial geniculate nucleus of 
the thalamus, and in large scattered cells of the superior colliculus. 
Higher resolution images of the cells expressing p, 6, and K receptor 
mRNA in the substantia nigra and ventral tegmental area are provided 
in Figure 15. Scale bar = 1,000 pm. 
Fig. 7. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression at the level of the caudal midbrain. p Cellular 
expression is localized in the presubiculum, rostral interpeduncular 
nucleus, oculomotor nucleus, scattered large cells of the superior 
colliculus, and deep mesencephalic nucleus. Cells expressing 6 receptor 
mRNA are similarly localized in the rostral interpeduncular nucleus in 
addition to the magnocellular neurons of red nucleus. Cells expressing K 
receptor mRNA have a more widespread distribution at  this level, 
however, with K receptor mRNA expression in the caudal linear raphe 
nucleus, substantia n i g a  (pars reticulata and pars compacta), central 
gray, superior colliculus, and DpMe. A high-resolution image of cells in 
the caudal linear raphe that express K receptors is provided in Figure 
16. Scale bar = 1,000 pm. 
expression levels are moderate in most divisions of the bed 
nucleus stria terminalis, high levels of K receptor mRNA are 
seen in the medial posterior division. Small cellular groups 
embedded within the stria terminalis also express p and K 
receptor mRNAs. 
The distribution of cells expressing opioid receptor mR- 
NAs varies markedly in the striatum. In the caudate- 
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Fig. 8. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression at the level of the pontine nuclei. 6 Receptor mRNA 
expression is prominent in the pontine nuclei, reticulotegmental nucleus 
of the pons, and anterior tegmental nucleus, all regions not demonstrat- 
ing p or K receptor mRNA expression. As was shown in preceding 
figures, cells expressing 6 receptor mRNA are also prominent in the 
occipital and entorhinal cortices. Cells expressing p receptor mRNA are 
localized in the central and external cortices of the inferior colliculus, 
pontine central gray, lateral lemniscus, and median raphe. In contrast, 
cells expressing K receptor mRNA are restricted to the dorsal and 
external cortices of the inferior colliculus. Other regions expressing K 
receptor mRNA include layers 5 and 6 of the occipital cortex, pontine 
central gray, and median raphe. A higher resolution image of the cells in 
the median raphe expressing p receptors is provided in Figure 16. Scale 
bar = 1,000 pm. 
Fig. 9. Darkfield autoradiograms comparing p, 6, and K mRNA 
expression at the level of the locus coeruleus and parahrachial nucleus. 
p And K receptor mRNA expression is observed in LC and PB nucleus, 
regions of no or low 6 receptor mRNA expression. In contrast, cells 
expressing 6 receptor mRNA are localized in the pontine nuclei and the 
reticulotegmental nucleus of the pons. Cells expressing p and K receptor 
mRNA are also observed in the large scattered cells of the pontine 
reticular nucleus and in the dorsal raphe. Scale bar = 500 pm. 
Fig. 10. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression in the rat brainstem. Cells expressing p. receptor 
mRNA are prominent in the rostral portion of the nucleus of the 
solitary tract and in scattered cells of the intermediate and gigantocellu- 
lar reticular nuclei. Cells expressing 6 and K receptor mRNAs are 
similarly distributed in the intermediate and gigantocellular reticular 
nuclei, with 6 expression also high in the cells of the spinal trigeminal 
nucleus and K receptor expression found in the raphe obscurus. Cells in 
the rostral nucleus of the solitary tract also express K receptor mRNA, 
but their levels of expression are lower than those observed for p. 
Higher resolution images of opioid receptor mRNA expression in the 
raphe obscurus, nucleus of the solitary tract, and gigantocellular 
reticular field are provided in Figures 16, 18, and 19. Scale bar = 
500 pm. 
Fig. 11. Darkfield autoradiograms comparing p, 6, and K receptor 
mRNA expression in the caudal brainstem. Cells expressing p receptor 
mRNA are localized in nucleus gracilis, nucleus cuneatus, and dorsal 
motor nucleus of vagus in addition to scattered cells of the medullary 
reticular field. Cells expressing 6 receptor mRNA have a more limited 
distribution, with high levels in the lateral reticular nucleus. In 
contrast to the low number of cells in the commissural division of the 
nucleus of the solitary tract that express p receptor mRNA, cells 
expressing K receptor mRNA are prominent at this level of the solitary 
tract nucleus. Other regions expressing K receptor mRNA include the 
spinal trigeminal, dorsal motor nucleus of vagus, raphe obscurus, and 
medullary reticular field. Higher resolution images of opioid receptor 
mRNA expression in raphe obscurus and nucleus of the solitary tract 
are provided in Figures 16 and 19. Scale bar = 500 pm. 
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Fig. 12. Darkfield autoradiograms demonstrating the cellular expres- 
sion of k,  6, and K receptor mRNAs in the hippocampus and amygdaloid 
nuclei. Within the hippocampus, cells expressing p receptor mRNA (A) 
are scattered in the pyramidal cell layer, with occasional large cells 
observed in stratum oriens and radiatum. A few isolated, scattered cells 
expressing high levels of 6 receptor mRNA are visible in B. Within the 
amygdala, p receptor mRNA expression is high in the intercalated 
nuclei of the basolateral amygdala (C), whereas cells expressing IC 
receptor mRNA are found in the central and basolateral nuclei (F) as 
well as the posterior division of the medial nucleus (E). Cells expressing 
6 receptor mRNA are localized in several nuclei of the amygdala 
including the basolateral nucleus shown above (D). Scale bars = 
100 Fm. 
putamen, cells expressing p receptor mRNA are organized 
in cellular groups or patches (Figs. 3, 4, top; 13A) that 
extend ventrally into the nucleus accumbens. These cellu- 
lar p receptor patches vary in cell number and demonstrate 
a three-dimensional distribution, with the highest density 
of patches found in the rostra1 and dorsal striatum. Medial- 
lateral differences are also seen with a higher number of 
patches observed laterally. In addition to p receptor patches, 
a high level of p receptor mRNA expression is observed in a 
cell layer immediately adjacent to the corpus callosum, 
referred t o  as the subcallosal streak (Atweh and Kuhar, 
1977~). Surrounding the p patches are scattered cells in the 
striatal matrix that generally express lower levels of p 
receptor mRNA. In the caudal portion of the caudate- 
putamen, higher levels of p, 6, and K receptor mRNA 
expression are observed in the fundus striati. 
In the nucleus accumbens, cell clusters as defined by 
Herkenham et al. (1984) also express high levels of p 
receptor mRNA (Fig. 13C). These cellular clusters, which 
can be identified by Nissl staining, are found predominantly 
in the nucleus accumbens shell. Both the core and shell 
compartments of the nucleus accumbens express p recep- 
tors; however, expression levels are higher in the accum- 
bens shell and septal pole regions (Fig. 3, top). Farther 
ventrally, scattered cells expressing p receptor mRNA are 
found in the region of the olfactory tubercle; however, they 
are not localized to the islands of Calleja or the olfactory 
tubercle proper. 
In contrast to the patch- and cluster-like distribution of 
cells expressing p receptor mRNA, cells expressing 6 recep- 
tors have a more homogeneous distribution in the caudate- 
putamen and nucleus accumbens (Figs. 3, 4, center; 13B). 
Although rostral-caudal differences in 6 receptor expression 
are not prominent, higher numbers of cells expressing 6 
receptor mRNA are observed in the lateral caudate- 
putamen that likely contribute to the higher amounts of 6 
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Fig. 13. Darkfield autoradiograms demonstrating the cellular expres- 
sion of p, 6, and K receptor mRNAs in the caudate-putamen and nucleus 
accumbens. Cells expressing p receptor mRNA are distributed in 
patches in the CPu (A) or as cellular groups or clusters in the Acb (C). 
Regions highlighted by arrowheads represent cell clusters in the 
nucleus accumbens that can be identified with Nissl staining (C). 
Similar but more densely organized clusters of cells in the nucleus 
accumbens express K receptor mRNA (D). In contrast, cells expressing 6 
receptor mRNA are more homogeneously distributed in the CPu (B), 
with higher numbers of cells in the lateral CPu. In addition, a small 
proportion of caudate-putamen cells, possibly cholinergic, expresses 
particularly high levels of 6 receptor mRNA. An example of one of these 
cells has been included as the inset in B. The dashed lines in C and D 
define the border of the anterior commissure. Scale bars = 100 wm in 
A,C,D, 1,000 pm in B, 10 pm in inset. 
receptor binding seen in the lateral striatum. Scattered 
among the cells expressing a moderate level of 6 receptor 
mRNA is a small population of large cells that contain high 
levels of 6 receptor mRNA (Fig. 13B). These cells are 
predominantly localized in the caudate-putamen and may 
be the large cholinergic neurons found in the striatum. 
Although not apparent from Figure 3, higher levels of 6 
receptor mRNA are observed in the accumbens shell and 
septal pole regions as compared to the core. More ventrally, 
high levels of 6 receptor mRNA expression are also observed 
in the olfactory tubercle (Fig. 3, center). 
Cells expressing K receptor mRNA have a different distri- 
bution in the striatum, with high levels of expression in the 
nucleus accumbens and olfactory tubercle. In the nucleus 
accumbens, K receptor expression is not homogenous, with 
cells expressing K receptors organized into clusters (Fig. 
13D) that can be identified in Nissl-counterstained sections. 
Differences in expression levels are also seen in the compart- 
ments of the nucleus accumbens, with higher levels seen in 
the shell and septal pole regions (Fig. 3, bottom). In the 
dorsal striatum, cells expressing K receptor mRNA are 
localized in the medial and ventral caudate-putamen, avoid- 
ing the lateral quadrant where 6 receptor mRNA expression 
is highest. Higher K receptor mRNA expression is also 
observed in the dorsomedial portion of the caudate- 
putamen, which is thought to be the rodent equivalent of 
the caudate nucleus. 
Cells of the globus pallidus and ventral pallidum express 
p, 6, and K receptor mRNAs. In the globus pallidus, 
scattered large cells express high levels of p and K receptor 
mRNAs. Farther caudally in the globus pallidus at the level 
of the thalamus, cells expressing p and K receptors are less 
widely distributed and have a more clustered appearance. 
In the rostra1 ventral pallidum, cells expressing p and K re- 
ceptors are localized in small groups ventral to the nucleus 
accumbens and become more widely scattered in the caudal 
ventral pallidum. Despite a similar distribution in the 
globus pallidus and ventral pallidum, colocalization studies 
are necessary to determine whether p and K mRNAs are 
localized in the same cells. Delta receptor mRNA expression 
is comparatively low in the globus pallidus and ventral 
pallidum, with a few scattered cells detected in both regions. 
In the septal nuclei, cells expressing p receptor mRNA 
are localized in the medial and lateral divisions as well as 
the septohypothalamic nucleus, where expression levels are 
high (Figs. 3, 4, top). p Receptor mRNA levels are high 
throughout the rostral-caudal extent of the medial septum; 
however, differences are seen in the lateral septum, where p 
receptor mRNA expression is higher in the caudal portion 
of the intermediate lateral septum (Fig. 4, top). In contrast, 
cells expressing K receptor mRNA are widely distributed in 
the lateral and medial septum and have a moderate level of 
expression (Figs. 3, 4, bottom), whereas those expressing 6 
receptors have comparatively low levels of expression in the 
medial and lateral septum, with only a few cells detected. 
Ventral to the septum, cells of the diagonal band of Broca 
contain p, 6, and K receptor mRNAs (Fig. 3). Moderate 
levels of p, 6, and K receptor expression are seen in scattered 
cells in the vertical and horizontal limbs of the diagonal 
band of Broca. 
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Other regions in the telencephalon that express opioid 
receptors include the endopiriform nucleus, claustrum, and 
parastrial nucleus (Figs. 3, 4), where high levels of K 
receptor mRNA are observed. Whereas the cells in the 
parastrial nucleus express exclusively K receptors, cells in 
the claustrum also demonstrate high levels of 6 and low 
levels of receptor mRNA, and those in the endopiriform 
nucleus express low to moderate levels of p and 6 receptor 
mRNAs. 
Diencephalon 
There are marked differences in the distribution of cells 
expressing p, 6, and K receptor mRNAs in the diencephalon. 
Receptor mRNA expression is high in most thalamic 
nuclei, whereas cells expressing K receptors have a more 
limited distribution and are primarily localized in the 
medial thalamic nuclei. In the hypothalamus, where K 
receptor mRNA expression predominates, cells expressing 
receptor mRNA maintain a widespread distribution, but 
high levels of expression are limited to a few nuclei. Cells 
expressing 6 receptor mRNA also have a limited distribu- 
tion in the hypothalamus, and expression levels are compar- 
atively low in most regions except for the ventromedial 
hypothalamus. 
High levels of p receptor expression are observed in the 
medial habenula, paraventricular, mediodorsal, laterodor- 
sal, centromedial, paracentral, interanteromedial, gelatino- 
sus, reuniens, rhomboid, ventrolateral, ventromedial, para- 
fascicular, and posterior thalamic nuclei (Fig. 5, top). Little, 
if any, p. receptor mRNA could be detected in the anterior 
thalamic nuclear groups of the anterodorsal and anteroven- 
tral nuclei or in the lateral habenula. Rostral-caudal differ- 
ences in @ receptor expression are observed in the reticular 
nucleus, where higher expression levels are detected in its 
most rostral portion. Lower levels of p receptor mRNA 
expression are seen in several other nuclei including the 
ventral posterior lateral nucleus and the zona incerta. 
Differences are also seen in the geniculate bodies, where 
high levels of p receptor mRNA expression are observed in 
the medial and subgeniculate nuclei (Fig. 6, top), whereas 
only moderate levels are detected in the lateral geniculate 
body. 
In contrast, high levels of K receptor expression in the 
thalamus are limited to the paraventricular, centromedial 
(Fig. 5 ,  bottom), paracentral, and parafascicular nuclei, 
with moderate levels of expression in the lateral habenula, 
laterodorsal nucleus, rhomboid, zona incerta, and the ven- 
tral lateral geniculate body. Expression of 6 receptor mRNA 
in the thalamus is low, with cells localized in the laterodor- 
sal, reticular, and parafascicular nuclei as well as the zona 
incerta and lateral geniculate body. 
In the rostral hypothalamus, cells expressing p. and K 
receptor mRNAs are observed in the medial preoptic area 
(Fig. 41, with high levels of p receptor mRNA expression 
also seen in the medial preoptic nucleus. Cells expressing p 
and K receptor mRNAs are widely distributed, with scat- 
tered cells in the medial preoptic, median preoptic, and 
lateral preoptic areas. Differences are seen within the 
medial preoptic area, where higher levels of p receptor 
expression are observed in the lateral portion, whereas cells 
expressing K receptor mRNA have a more medial localiza- 
tion (Fig. 4). In contrast, only low levels of 6 receptor mRNA 
expression can be detected in scattered cells of the medial 
preoptic area and are observable only at  high magnification 
More caudally within the hypothalamus, high levels of K 
receptor mRNA expression are observed in the paraventricu- 
lar, periventricular, supraoptic, and suprachiasmatic nuclei 
of the hypothalamus (Fig. 14A,C,E,G). In the paraventricu- 
lar nucleus, cells in the anterior parvocellular, medial 
parvocellular, and magnocellular divisions express K recep- 
tor mRNA, with particularly high levels of expression in the 
magnocellular neurons. The scattered distribution of the 
magnocellular neurons in the paraventricular and supraop- 
tic nuclei that express K receptor mRNA (Fig. 14A,C) 
suggests that this represents only a subpopulation of 
magnocellular neurons. Similarly, by comparing Nissl- 
counterstained sections, it is clear that only the cells 
localized in the ventral suprachiasmatic nucleus express K 
receptor mRNA (Fig. 14E,G). In contrast, comparatively 
low levels of receptor mRNA expression are observed in 
scattered cells of the paraventricular, periventricular, and 
supraoptic nuclei, with no cells detected in the suprachias- 
matic nucleus. 6 Receptor mRNA expression is undetect- 
able in the periventricular and suprachiasmatic nuclei of 
the hypothalamus, with only low levels of expression ob- 
served in the paraventricular and supraoptic nuclei. 
High levels of K receptor mRNA expression are also seen 
in the cells of the arcuate nucleus, median eminence, and 
infundibular stem (Fig. 14B,D,E), where K receptors may 
serve to regulate neuroendocrine release. Within the me- 
dian eminence, K receptor mRNA is localized in the ependy- 
mal cells immediately adjacent to the floor of the third 
ventricle and in scattered neurons in the inner and outer 
cell layers (Fig. 14D). Low levels of p receptor mRNA 
expression are seen in the arcuate nucleus, with no detect- 
able p. or 6 expression in the cells of the median eminence 
and infundibulum. Opioid receptor mRNA expression ex- 
tends to the anterior and lateral hypothalamic nuclei, with 
scattered cells expressing moderate levels of p and K 
mRNAs. Only low levels of 6 receptor mRNA expression are 
seen in scattered cells of the lateral hypothalamus. 
Cells expressing high levels of K receptor mRNA are 
localized in both the dorsomedial and the ventromedial 
nuclei, whereas those expressing 6 receptors are localized in 
the ventromedial nucleus of the hypothalamus, with no 
cells detected in the dorsomedial nucleus. Within the 
ventromedial nucleus of the hypothalamus, cells expressing 
K mRNA have a more limited distribution, predominantly 
localized in the dorsomedial subdivision. Cells expressing p. 
receptor mRNA demonstrate a third pattern, with low 
levels of expression in dorsomedial nucleus and no detect- 
able cells in the ventromedial nucleus of the hypothalamus. 
Farther caudally, high levels of p and K receptor expression 
are observed in the posterior nucleus of the hypothalamus, 
where no 6 receptor mRNA expression can be detected. 
In the mammillary complex, cells with high levels of p 
receptor mRNA are observed in the supramammillary 
nucleus, with only low levels in the medial median mammil- 
lary and premammillary nuclei. In contrast, 6 receptor 
mRNA expression cannot be detected in the mammillary 
nuclei, and K receptor expression is limited to the ventral 
premammillary and supramammillary nuclei. No opioid 
mRNA expression could be detected in the lateral mammil- 
lary nucleus of the hypothalamus. 
Mesencephalon 
Cells expressing p., 6, and K receptor mRNAs are localized 
in the superior and inferior colliculi (Figs. 6-8). In the 
superior colliculus, a laminar pattern is seen, with the 
MU, DELTA, AND KAPPA RECEPTOR mRNA IN THE RAT CNS 425 
Fig. 14. K Receptor mRNA expression in the nuclei of the hypothala- 
mus, median eminence, and infundibulum. Darkfield autoradiograms 
demonstrate that the cells expressing K receptor mRNA are localized in 
the paraventricular (A), supraoptic (C), and suprachiasmatic (E) nuclei 
of the hypothalamus, where they may play a role in response to stress 
and in maintaining electrolyte balance. As can be seen from the 
corresponding brightfield image (G), only the cells in the ventral 
portion of the suprachiasmatic nucleus express K receptor mRNA. 
Similarly, only a subpopulation of magnocellular neurons in the 
paraventricular and supraoptic nuclei expresses K receptor mRNA. 
Darkfield images show that cells in the arcuate nucleus (B), median 
eminence (D), and infundibular stem (F) also express K receptor mRNA 
and may be of importance in hormonal regulation. Within the median 
eminence, both ependymal cells immediately adjacent to the base of the 
third ventricle (3V) and scattered cells, as indicated by arrowheads (D), 
in the inner and outer layers of the median eminence express K receptor 
mRNA. Similarly, in comparing the brightfield (H) and darkfield (F) 
images, it appears that cells in the infundibular stem express K 
receptors. The same cells are highlighted by arrows in F (darkfield) and 
H (brightfield). Scale bars = 100 pm. 
highest level of c~ receptor mRNA expression detected in the 
large scattered cells in the intermediate and deep layers. 
Lower levels of p receptor expression are seen in the 
superficial gray layer, with no detectable p receptor mRNA 
expression in the optic nerve layer. Cells expressing 6 
receptor mRNA are also localized to the intermediate and 
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Fig. 15. Darkfield autoradiograms showing the cellular expression 
of IJ., 6, and K receptor mRNAs in the substantia nigra and ventral 
tegmental area. Regions indicated by boxes in A-C have been magnified 
and presented in D,F-L. A schematic drawing is provided in E that 
illustrates the divisions of the substantia nigra and the level of the 
ventral tegmental area examined. Cells expressing K receptor mRNA 
are prominent in the ventral tegmental area (F); substantia nigra, pars 
compacta (I); and substantia nigra, pars reticulata (L). Within the 
deep layers of the superior colliculus; however, compar- 
atively fewer cells and lower levels of expression are ob- 
served. In contrast to the laminar distribution of cells 
expressing p and 6 receptor mRNAs, cells expressing K 
receptors have a more homogeneous distribution in the 
superior colliculus, with moderate levels of expression in 
the superficial gray, optic nerve, intermediate gray, and 
deep gray layers. In the inferior colliculus, cells expressing 
p and 6 receptor mRNAs are localized in the dorsal, central, 
substantia nigra, far fewer cells expressing K receptor mRNA are 
observed in the pars lateralis, a region where 6 receptor mRNA 
expression is observed (H). Scattered cells expressing 6 receptor mRNA 
are also observed in the suhstantia nigra, pars reticulata, and are more 
abundant in the dorsolateral portion (K). In contrast, comparatively 
few cells expressing IJ. receptor mRNA are seen in the ventral tegmental 
area (D) and substantia nigra, pars compacta (G)  and pars reticulata 
(J). Scale bars = 500 pm in C, 100 Km in F,I,L. 
and external cortex, whereas cells expressing K receptors 
have a more limited distribution, localized primarily in the 
dorsal and external cortex (Fig. 8). Despite a similar 
anatomical distribution of p and 6 receptor mRNAs within 
the inferior colliculus, 6 expression levels are low compared 
to I*. 
In the rostral central gray, moderate p receptor mRNA 
expression levels are observed, with cells localized predomi- 
nantly in the ventrolateral portion. Cells expressing K 
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Fig. 16. Darkfield autoradiograms demonstrating the cellular expres- 
sion of p and K receptor mRNAs in the raphe nuclei. Cells expressing p 
receptor mRNA are localized in the median raphe (A) and raphe 
magnus (C), whereas cells expressing K receptor mRNA are localized in 
the caudal linear raphe (B) and raphe obscurus (D). Scale bars = 
100 pm. 
receptor mRNA are more widely distributed in the central 
gray, with moderate levels of expression in the dorsal and 
ventrolateral central gray. p And K receptor mRNA expres- 
sion extends to the pontine central gray, where expression 
levels are higher. In contrast, only low levels of 6 receptor 
mRNA can be detected in the rostral central gray with little, 
if any, observed in the pontine central gray. 
K Receptor mRNA expression is prominent in the cells of 
the substantia nigra and the ventral tegmental area (Figs. 
6,  15). In the substantia nigra, cells expressing high levels 
of K receptor mRNA are predominantly localized in the 
medial portion of the pars compacta (Fig. 1511, with compar- 
atively fewer cells and lower levels of expression in the pars 
lateralis. Moderate levels of K receptor expression are also 
seen in large scattered cells of the pars reticulata, with 
higher expression levels in the caudal portion of the pars 
reticulata (Figs. 6 vs. 7; E L ) .  In the ventral tegmental area, 
cells expressing high levels of K receptor mRNA are most 
dense immediately adjacent to the substantia nigra, pars 
compacta, having a more scattered distribution in the 
remaining tegmental area. 6 Receptor expression is compar- 
atively low in the substantia nigra and ventral tegmental 
area, with cells localized predominantly in the lateral pars 
compacta (Fig. 15H) and widely scattered in the ventral 
tegmental area. Cells of the pars reticulata also express 6 
receptor mRNA, with moderate levels of expression in the 
lateral pars reticulata (Fig. 15K). Moderate levels of K and 
low levels of 6 receptor mRNA expression are observed in 
the subthalamic nucleus, where they may serve to regulate 
nigrostriatal systems. 
In contrast, relatively few cells expressing p receptor 
mRNA are seen in the ventral tegmental area and in the 
pars compacta and pars reticulata of the substantia nigra 
(Fig. 15D,G,J).Within the pars compacta, a higher number 
of cells expressing p receptor mRNA are localized in the 
lateral pars compacta, a region of comparatively lower K 
receptor mRNA expression. Rostral-caudal differences in p 
receptor mRNA expression are observed in the ventral 
tegmental area and substantia nigra, pars reticulata, with 
higher levels of + receptor expression observed caudally. 
In the interpeduncular complex, p, 6, and K receptor 
mRNAs are expressed (Fig. 7). High levels of p receptor 
mRNA are observed in the cells of the rostral interpeduncu- 
lar nucleus, with a few cells detected in the caudal nucleus 
demonstrating high levels of expression. Only moderate 
levels of p receptor expression are seen in the intermediate 
subdivision of the interpeduncular nucleus. Cells express- 
ing 6 receptor mRNA are primarily localized in the rostral 
interpeduncular, whereas those expressing low levels of K 
receptor mRNA are scattered in the rostral, caudal, and 
intermediate subdivisions. 
Other regions in the mesencephalon that express high 
levels of opioid receptor mRNAs are the red nucleus, the 
oculomotor nucleus, and the nucleus of the lateral lemnis- 
cus. The magnocellular division of the red nucleus is one of 
the few regions in the midbrain of relatively high 6 receptor 
mRNA expression. This region contains no p or K receptor 
mRNA expression and suggests the importance of 6 recep- 
tors in the corticorubrospinal pathway. High levels of p 
mRNA and moderate levels of 6 mRNA are observed in the 
cells of the oculomotor nucleus, where they may be impor- 
tant in eye muscle control (Fig. 7). The cells of the lateral 
lemniscus (Fig. 8) predominantly express p receptor mRNA, 
however, with only a low level of 6 and K expression in the 
ventral nucleus of the lateral lemniscus. 
Cells expressing p, 6, and K mRNAs are observed scat- 
tered in the deep mesencephalic nucleus (Fig. 7) .  Cells 
expressing high levels of p, 6, and K mRNA extend caudally 
into the brainstem, where large numbers of cells are seen 
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scattered throughout the pontine and medullary reticular 
nuclei (Figs. 8-11). 
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Met- and mylencephalon 
The cells of the pontine nuclei contain the highest levels 
of 6 receptor mRNA found in the rat brain (Figs. 8, 9). High 
6 receptor mRNA expression is not limited to the pontine 
nuclei but extends to the reticulotegmental nucleus of the 
pons, with lower levels of expression in the anterior tegmen- 
tal nucleus. These regions demonstrate predominantly 6 
receptor mRNA expression, with no detectable p or K 
receptor mRNA expression. Low levels of p and K receptor 
mRNA expression are seen, however, in the cells of the 
dorsal tegmental nucleus, with K receptor mRNA expres- 
sion extending to the laterodorsal tegmental nucleus. 
Cells of the raphe nuclei, on the other hand, predomi- 
nantly express K and receptor mRNAs. High levels of K 
receptor mRNA are observed in the caudal linear and dorsal 
raphe, as well as the raphe obscurus (Figs. 7,9-11,16B,D), 
whereas moderate levels are seen in the median raphe (Fig. 
8, bottom). p Receptor mRNA expression differs in the 
raphe nuclei, with high levels of expression in the median 
raphe and in scattered large cells of the raphe magnus 
(Figs. 8; 16A,C). Lower levels of p receptor expression are 
seen in the caudal portion of the dorsal raphe, and, in the 
caudal linear raphe, only a few cells expressing p receptor 
mRNA can be detected. In comparison, low levels of 6 
mRNA are seen in the median raphe and raphe magnus, 
and moderate levels are observed in raphe pallidus. 
Cells in the locus coeluleus and parabrachial nucleus 
express p and K receptor mRNAs (Fig. 9). High levels of p 
receptor mRNA expression are seen in the locus coeruleus 
and in the lateral, medial, and ventral divisions of the 
parabrachial nucleus. K Receptor mRNA expression is also 
high in the locus coeruleus; however, the number of cells 
expressing K receptor mRNA is lower compared to those 
expressing p. Similarly, cells expressing K receptor mRNA 
in the parabrachial nucleus are predominantly localized in 
the lateral division, with fewer cells in the medial and 
ventral parabrachial nucleus. No 6 mRNA expression can 
be detected in the locus coeruleus, and low levels of 
expression are observed in the parabrachial nucleus. 
In the trigeminal nuclei, S receptor mRNA expression is 
high in the cells of the motor and spinal trigeminal (Fig. 
lo),  with moderate levels of expression in the principal 
sensory nucleus. Comparatively few cells expressing low 
levels of p and K receptor mRNAs are seen in the principal 
sensory and motor trigeminal. In the spinal trigeminal 
nucleus, where p receptor mRNA expression is low, cells 
expressing K receptors have a high level of expression in the 
superficial portion of the caudal spinal trigeminal nucleus 
(Fig. 11, bottom). High levels of K receptor mRNA are also 
seen in the paratrigeminal nucleus (Fig. 17C). 
p Receptor mRNA expression is high in the olivary 
complex. Scattered cells in the medial ventral, lateral 
ventral, superior paraolivary, and lateral superior olive 
express high levels of p receptor mRNA, with no cells 
detected in the inferior olive. Comparatively, low levels of S 
and K receptor mRNA expression is seen in the medial 
ventral, lateral ventral, superior paraolivaq, and lateral 
rostral Preolivary nucleus. In the inferior olive, no 6 
receptor mRNA expression can be observed, but cells 
expressing K receptor mRNA are localized in the p and N 
subunits. 
Fig. 17. Darkfield autoradiograms showing the cellular expression 
of h 6, and K receptor mRNAs in brainstem nuclei. High levels of I.L 
receptor mRNA expression are observed in nucleus ambiguus (A), 
linear nucleus of the medulla (B) and the paratrigeminal (C) nucleus, 
respectively. Scale bars = 100 km. 
superior Olive? with moderate levels Of expression in the whereas cells expressing 6 or receptor mRNA are localized in the 
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Fig. 18. Darkfield autoradiograms demonstrating the cellular expres- 
sion of p, 6, and K receptor mRNAs in the dorsal paragigantocellular 
and the gigantocellular reticular nuclei. Regions highlighted in B 
indicate the areas of the brainstem examined in A,C-F. Large cells in 
the dorsal paragigantocellular nucleus express p (A) and K (C) receptor 
mRNAs. More ventrally, gigantocellular reticular nucleus cells express- 
ing p (D), 6 (El, and K (F) receptor mRNAs are observed. Scale bars = 
100 km. 
Fig. 19. Darkfield autoradiograms demonstrating the cellular expres- 
sion of p, 6, and ti receptor mRNAs in the nucleus of the solitary tract 
and the hypoglossal nucleus. Rostrd-caudal differences in and ti 
receptor mRNA expression are observed in the nucleus of the solitary 
tract, with p receptor mRNA expression predominantly in the rostra1 
Moderate levels of 6 and K receptor mRNA expression are 
observed in the cochlear nucleus. A few cells expressing p 
receptor mRNA are also observed in the cochlear nucleus; 
however, their levels of expression are low. Similarly, in the 
vestibular nuclei, moderate levels of 6 expression are seen 
division (A vs. C), whereas cells expressing K receptor mRNA are found 
in the commissural division (D). In addition to the nucleus of the 
solitary tract, cells of the dorsal motor vagus nucleus express p (C) and 
K (D) receptor mRNAs. B shows cells of the hypoglossal nucleus that 
express exclusively 6 receptors. Scale bars = 100 pm. 
in the medial and lateral nuclei, whereas only low levels of 
and K receptor mRNA expression can be detected. 
Scattered in the brainstem, the gigantocellular cells 
express high levels of k, 6, and K mRNAs (Fig. 18). 
Gigantocellular cells expressing p, 6, and K mRNA are 
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Fig. 20. Darkfield autoradiograms demonstrating the cellular expres- 
sion of p, 6, and K receptor mRNAs in the dorsal root ganglia and 
thoracic spinal card (C-G). A large number of dorsal root ganglia cells 
express p and K receptor mRNAs (E,G) compared to those expressing 6 
receptor mRNA (F). In addition, the subpopulation of dorsal root 
ganglia cells expressing the opioid receptor mRNAs appears to differ 
with 6 receptors expressed in large-diameter cells, p expressed in both 
widely distributed and are also seen in the dorsal paragigan- 
tocellular nucleus (Fig. 18A,C). p, 6, And K mRNA expres- 
sion extends laterally to the intermediate reticular nucleus 
and caudally into the medullary reticular nucleus, where 
high levels of expression are observed (Figs. 10,111. 
Marked rostral-caudal differences are observed in the 
expression of opioid receptor mRNAs in the nucleus of the 
solitary tract. In the rostral nucleus of the solitary, p 
expression levels are higher compared to the commissural 
division, where far fewer cells expressing p mRNA are 
observed (Figs. 10 vs. 11; 19A,C). Cells expressing K recep- 
tor mRNA, on the other hand, are predominantly localized 
in the commissural division of the nucleus of the solitary 
tract, with comparatively fewer cells expressing K receptor 
mRNA in the rostral portion of the nucleus of the solitary 
tract (Figs. 10 vs. 11; 19C). In contrast, little if any 6 
receptor mRNA expression can be observed in the rostral or 
commissural nucleus of the solitary tract. 
receptor mRNA expression is In the caudal brainstem, 
medium- and large-diameter cells, and K predominantly expressed in 
medium-diameter neurons. A Nissl-stained dorsal root ganglia section 
is provided in A and a schematic drawing of the thoracic spinal in B for 
comparison. C and D demonstrate the large neurons expressing either 
p or 6 receptor mRNAs in the ventral horn of the spinal cord. Scale 
bars = 100 bm. 
vagus, nucleus cuneatus, and nucleus gracilis (Figs. 10, 11, 
17A, 19C). The cells in the nucleus ambiguus express 
exclusively p receptor mRNA, with no 6 or K receptor 
expression observed. Similarly, in the nucleus cuneatus, p 
receptor expression predominates, with only a few scattered 
cells expressing 6 and K receptor mRNAs observed. 6 
Receptor mRNA expression is high, however, in the exter- 
nal cuneate nucleus, where p and K expression is not 
detected. Cells of the dorsal motor nucleus of vagus, in 
addition to demonstrating high levels of p receptor mRNA, 
also express high levels of K receptor mRNA, with no 
detectable 6 receptor expression. Low K receptor mRNA 
expression is also seen in the nucleus gracilis. 
Several regions in the brainstem exclusively express 6 
receptor mRNA. These nuclei include the trapezoid nucleus, 
linear nucleus of the medulla (Fig. 17B), hypoglossal nucleus 
(Fig. 19B), and lateral reticular nucleus (Fig. ll), where 
moderate to high levels of 6 receptor mRNA expression are 
observed, with no I*. or K receptor mRNAs detected. Cells in 
high in the nucleus ambiguus, dorsal motor nucleus of the prepositus hypoglossal nucleus also express high levels 
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of 6 receptor mRNA and moderate levels of K receptor 
mRNA. 
In the cerebellum, cells in the granular cell layer express 
6 receptor mRNA, with no p or K receptor mRNA detected. 
In addition to the lobules of the cerebellum, cells in the 
interposed and medial cerebellar nuclei express moderate 
levels of 6 receptor mRNA, with low levels of p and K 
receptor mRNA expression. Cells in the lateral cerebellar 
nucleus, however, fail to show any p, 6, or K receptor mRNA 
expression. 
Spinal cord and dorsal root ganglia 
In the spinal cord, cells expressing p, 6, and K receptor 
mRNA are distributed in the laminae of the dorsal and 
ventral horns. Cells expressing p receptor mRNA are 
localized predominantly in laminae 4, 5 ,  7, 8, and 10, with 
fewer cells observed in laminae 2 and 3 of the thoracic 
spinal cord (Fig. 20B,C). Cells expressing 6 receptor mRNA 
are also scattered in the dorsal and ventral horn and are 
localized in laminae 4, 5 ,  and 7-10, with a few cells in 
lamina 3 of the thoracic cord. In contrast, comparatively 
few cells expressing K receptor mRNA are detected in the 
thoracic spinal cord, localized predominantly in laminae 4, 
5,  7, and 10, with no cells detected in laminae 1-3 and 9. 
The localization of p and 6 receptor mRNA in large cells of 
the ventral horn suggests an opioid receptor expression in 
motor neurons of the spinal cord. 
p, 6, And K receptor mRNA expression is also observed in 
the cells of the dorsal root ganglia; however, the population 
of ganglia neurons in which the opioid mRNAs are localized 
may differ (Fig. 20). p Receptor mRNA expression, which is 
prominent in the dorsal root ganglia, is localized in me- 
dium- and large-diameter ganglion cells, whereas K receptor 
expression is localized in smaller diameter neurons (Figs. 
2OA,E,G). Comparatively fewer dorsal root ganglia neurons 
express 6 receptor mRNA, with 6 receptor expression 
localized predominantly in large-diameter neurons (Fig. 
20F). 
DISCUSSION 
The in situ hybridization results demonstrate a differen- 
tial localization of p, 6, and K mRNAs in the central nervous 
system, consistent with the unique physiological and phar- 
macological functions associated with each of the opioid 
receptors. These findings complement previous receptor 
autoradiographic studies demonstrating a differential distri- 
bution of the p, 6, and K binding sites in the CNS (McLean 
et al., 1986; Mansour et al., 1987, 1988; Sharif and Hughes, 
1989) and provide insights into the cellular localization of 
the opioid receptor mRNAs encoding these receptors and 
the neuronal circuits they may modulate. Cells expressing 
p receptor mRNA have a widespread distribution and are 
localized in such regions as the olfactory bulb, caudate- 
putamen, nucleus accumbens, lateral and medial septum, 
diagonal band of Broca, most thalamic nuclei, hippocam- 
pus, amygdala, medial preoptic nucleus, superior and infe- 
rior colliculi, central gray, dorsal and median raphe, raphe 
magnus, locus coeruleus, parabrachial nucleus, pontine, 
intermediate gigantocellular and medullary reticular nu- 
clei, nucleus ambiguus, nucleus of the solitary tract, nucleus 
gracilis and cuneatus, dorsal motor nucleus of vagus, spinal 
cord, and dorsal root ganglia. Cellular expression of 6 
receptor mRNA differs, with high levels of expression in 
such regions as the olfactory bulb, allo- and neocortical 
areas, caudate-putamen, nucleus accumbens, olfactory tu- 
bercle, ventromedial hypothalamus, hippocampus, amyg- 
dala, red nucleus, pontine nuclei, reticulotegmental nucleus, 
motor and spinal trigeminal, linear nucleus of the medulla, 
pontine and medullary reticular nuclei, lateral reticular 
nucleus, hypoglossal nucleus, spinal cord, and dorsal root 
ganglia. Cells expressing K receptor mRNA demonstrate a 
third pattern of expression, with cells localized in such 
regions as the lateral orbital and agranular insular cortices; 
entorhinal cortex; layers 5 and 6 of parietal, temporal, and 
occipital cortices; claustrum; endopiriform nucleus; nucleus 
accumbens; olfactory tubercle; medial preoptic area; bed 
nucleus stria terminalis; amygdala; most hypothalamic 
nuclei; median eminence; infundibulum; paraventricular 
and centromedial nuclei of the thalamus; zona incerta; 
substantia nigra; ventral tegmental area; central gray; 
dorsal and laterodorsal tegmental nuclei; raphe nuclei; 
pontine and medullary reticular nuclei; locus coeruleus; 
parabrachial nucleus; paratrigeminal and spinal trigeminal 
nuclei; nucleus of the solitary tract; spinal cord; and dorsal 
root ganglia. 
Given the high nucleic acid and amino acid homologies of 
the cloned p, 6, and K receptors, the potential exists that a 
cRNA probe chosen to identify a specific mRNA may 
cross-hybridize to another opioid receptor type. This risk is 
mitigated by the facts that 1) three distinct mRNA distribu- 
tions are observed that correspond to well-known opioid 
receptor binding distributions and 2) when cRNA probes 
directed to different regions of the p or K receptors are used 
to identify their respective mRNA distributions, distinct p 
or K mRNA expression patterns are observed (Mansour et 
al., 1994a,b). These p and K mRNA expression patterns 
differ from those seen with 6 receptor cRNA probes pre- 
sented here. 
Although it is unlikely, then, that the cRNA probes used 
under the present conditions are cross-hybridizing to an- 
other cloned receptor, it is possible that they are labeling 
multiple mRNAs. The intronic organization of the p, 6, and 
K genes suggests that alternative splicing may produce 
multiple mRNA forms and is consistent with the multiple 
mRNA bands observed with Northern blots of the p and 6 
receptors (Evans et al., 1992; Fukada et al., 1993; Thomp- 
son et al., 1993). Insofar as the nucleic acid sequences of 
these alternatively spliced mRNAs have not been identified, 
it is difficult to know whether the in situ hybridization 
probes used in this study hybridize to one or more of these 
mRNAs. Clearly, this is an important consideration for 
future studies, in that the levels of receptor mRNA expres- 
sion and their response to regulatory stimuli can vary 
markedly between alternatively spliced forms of the same 
receptor (Amauld et al., 1991; Neve et al., 1991). In 
addition, pharmacological and receptor binding studies 
suggest the presence of subtypes for each class of receptors 
(Wolozin et al., 1981; Iyengar et al., 1986; Clark et al., 1989; 
Rothman et al., 1989; Jiang et al., 1991; Sofuoglu et al., 
19911, and it is unclear whether these represent alterna- 
tively spliced forms, distinct gene products, or differential 
posttranslational processing. 
A finding not emphasized in the results that needs to be 
discussed is that, although expression levels of each of the 
receptor mRNA differ between brain regions, their overall 
levels of expression in the rat CNS are quite comparable. 
This is evidenced from the similar film exposure times used 
to identify the I*, 6, and K mRNAs and by similar results 
obtained with Northern blot analysis (Fukada et al., 1993; 
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Thompson et al., 1993; Yasuda et al., 1993). This is 
interesting, in that the numbers of K receptor binding sites 
in the rat brain are significantly lower than numbers of p or 
6 sites as measured by binding studies (Gillan and Koster- 
litz, 1982), and it suggests a differential translation or 
transcriptional regulation of the K opioid receptors. Clearly, 
more research is necessary to confirm this suggestion, and 
controls for cRNA length, exposure time, and tissue penetra- 
tion are necessary. 
A major advantage in using in situ hybridization tech- 
niques over traditional receptor autoradiography to localize 
receptors is the cellular resolution that can be achieved. 
Specific mRNAs can be localized to single cells, often aiding 
in characterizing their function. The identification of K 
receptor mRNA in the cells of substantia nigra (SN) and 
ventral tegmental areas (VTA), for example, suggests a 
localization in dopamine-synthesizing cells and a possible 
modulation of dopamine release. This conclusion is sup- 
ported by 6-hydroxydopamine lesion studies demonstrating 
a complete loss of K receptor mRNA in the SN and VTA 
following the selective ablation of dopamine neurons (Man- 
sour et al., unpublished observations) and by pharmacologi- 
cal studies showing that K agonists selectively decrease 
presynaptic dopamine release in the rat striatum (Mulder 
et al., 1984; Di Chiara and Imperato, 1988; Spanagel et al., 
1990, 1992). 
Similarly, the distinct 6 receptor mRNA distribution in 
the caudate-putamen is suggestive of a specific localization 
in cholinergic neurons. A moderate level of 6 receptor 
mRNA expression is observed in most medium-sized neu- 
rons of the caudate-putamen, with a small proportion of 
large, widely scattered neurons expressing high levels of 6 
receptor mRNA. This small population of large neurons has 
anatomical and morphological properties similar to those of 
the cholinergic neurons found in the striatum and suggests 
that 6 agonists may modulate release of acetylcholine. 
Pharmacological studies have demonstrated that selective 6 
and p agonists inhibit acetylcholine release from the stria- 
tum, consistent with this observation (Wood and Rackham, 
1981; Mulder et al., 1984). 
Other examples can be seen in the distribution of p 
receptor mRNA. Cells expressing p mRNA are localized in 
the locus coeruleus, suggesting a p modulation of norepi- 
nephrine (NE) release. The mechanism of action of p 
opioids on NE release is unclear; electrophysiological stud- 
ies (Aghajanian and Wang, 1986; North et al., 1987) suggest 
that p agonists selectively modulate the firing of locus 
coeruleus neurons, whereas other studies using cortical 
slice preparations (Mulder et al., 1987; Werling et al., 1987; 
Schoffelmeer et al., 1988) suggest an inhibition of NE 
release from cortical nerve terminals via a presynaptic 
mechanism. In that p receptor binding sites and mRNA are 
localized in the locus coeruleus and cortex, both mecha- 
nisms of action are possible. Given the comparatively lower 
number of cells in the locus coeruleus that express K 
compared to p, the ineffectiveness of K agonists to inhibit 
release (Mulder et al., 1987; Werling et al., 1987) may be 
due to a localization of K receptors in subpopulation norad- 
renergic neurons that do not project as extensively to the 
rat cortex. 6 Agonists are likely unable to directly inhibit 
NE release due to the absence of 6 receptors in the locus 
coeruleus. Furthermore, receptor binding and mRNA data 
suggest that 6 receptors are not on NE terminals in the 
cortex but may have a postsynaptic localization. 
In the hippocampus, the scattered nature of the p-express- 
ing cells in the pyramidal cell layer is consistent with a large 
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body of electrophysiological findings suggesting that these 
are inhibitory y-aminobutyric acidergic (GABAergic) inter- 
neurons (Nicoll et al., 1977, 1980; Zieglgansberger et al., 
1979; Madison and Nicoll, 1988). The distribution of cells 
expressing 6 receptor mRNA differs, with a moderate level 
of expression in most pyramidal cells and with occasional 
cells (possibly interneurons) expressing high levels of 6 
receptor mRNA. Cells expressing K receptor mRNA are not 
observed in the dorsal hippocampus but are localized to the 
stratum radiatum of the temporal hippocampus. 
In the case of serotonin regulation, the anatomical 
evidence suggests that IJ. and K receptors may be primarily 
involved. Although not all cells in the raphe nuclei contain 
serotonin, the high levels of K receptor mRNA expression in 
the caudal linear raphe, dorsal raphe, and raphe obscurus 
and of p receptor mRNA expression in the median raphe, 
dorsal raphe, and raphe magnus are consistent with a role 
of K and p receptors in regulating serotonin release (Yaksh 
and Tyce, 1979; VonVoigtlander et al., 1983). This is 
consonant with pharmacological data suggesting that sero- 
tonergic mechanisms are important in antinociceptive re- 
sponses mediated by p and K agonists CYaksh, 1979; VonVoi- 
gtlander et al., 1984; Ho and Takemori, 1989). A 
comparatively lesser role is likely played by 6 receptors in 
serotonin release, with a few cells localized in the raphe 
magnus and median raphe. 
The role of opioid receptors in modulating neuropeptide 
release and, particularly, the release of opioid peptides is 
less clear. The localization of K-expressing cells in such 
regions as the paraventricular magnocellular neurons, 
nucleus accumbens, and centrolateral nucleus of the amyg- 
dala, all of which contain prodynorphin-expressing cell 
bodies, suggests a possible K autoreceptor function. K 
Agonists have been demonstrated to inhibit the release of 
the vasopressin (AVP) and oxytocin ( O m ,  Slizgi and 
Ludens, 1982; Carter and Lightman, 1984; Bicknell et al., 
1985; Falke, 1988) and, presumably, the prodynorphin and 
proenkephalin peptides with which they are colocalized 
(Martin and Voigt, 1981; Watson et al., 1982; Whitnall et 
al., 1983). However, given that prodynorphin and proen- 
kephalin cleavage products are able to bind p, 6, and K 
receptors (Quirion and Pert, 1981; Wuster et al., 1981; 
Schultz et al., 1982; Quirion and Weiss, 1983; Shook et al., 
1988) and the often overlapping receptor and peptide 
distributions observed in many brain regions (Khachatu- 
rian et al., 1982, 1983; Fallon and Leslie, 19861, the precise 
relationships between the opioid peptides and potential 
autoreceptors are difficult to predict at  present. Clearly, 
more studies are necessary to colocalize the opioid peptides 
and opioid receptors in multiple brain regions before one 
can evaluate their precise relationships and to determine 
whether opioid peptides can modulate their own release. 
The localization of opioid receptor mRNAs within well- 
characterized circuits and neuronal systems can shed light 
on their functions. For example, both receptor autoradio- 
graphic (Atweh and Kuhar, 1977a-c; Herkenham and Pert, 
1980; Mansour et al., 1987) and in situ hybridization 
results presented here strongly suggest that opioid recep- 
tors are intimately involved in the processing of sensory, 
proprioceptive, and vestibular information. The type of 
opioid receptor predominantly involved is dependent on 
sensory modality and level of anatomical processing. In the 
olfactory system, for example, p and 6 receptors are likely 
important in the primary processing and integration of 
olfactory information. p- And &containing cells are local- 
ized in the main olfactory bulb and primary olfactory cortex 
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as well as more integrative olfactory processing regions 
such as the anterior olfactory nuclei, diagonal band of 
Broca, bed nucleus of the stria terminalis and endopiriform 
nucleus, amygdala, and entorhinal cortex. K Receptors, on 
the other hand, may play a more modulatory role, not 
localized to a large degree in the main and accessory 
olfactory bulbs and piriform cortex but expressed in regions 
that receive primary and secondary olfactory afferents such 
as the anterior olfactory nucleus, olfactory tubercle, amyg- 
dala, entorhinal cortex, nucleus of the lateral olfactory 
tract, and bed nucleus stria terminalis. The localization of 
cells expressing p receptor mRNA in the accessory olfactory 
bulb, bed nucleus of the accessory olfactory tract, medial 
amygdala, and posteromedial cortical amygdala suggests 
that predominantly p receptors process information from 
the cells in the vomeronasal organ, which may be important 
in sexual and aggressive behaviors (Winans and Powers, 
1977; Lehman and Winans, 1982). 
In the visual system, p, 6, and K receptor mRNAs are 
localized in the cells of the superior colliculus, lateral and 
ventral lateral geniculate, and visual cortex, suggesting 
that all three receptors may be involved in the processing of 
visual information. In the superior colliculus, cells express- 
ing p and 6 mRNA have a distinct laminar distribution, 
whereas those expressing K mRNA are more homoge- 
neously distributed, possibly reflecting differential process- 
ing of visual information such as orientation to visual 
stimuli. In addition to p and K, the localization of 6 receptor 
mRNA in the intermediate and deep layers of the superior 
colliculus is particularly interesting in view of the projec- 
tions of these layers to the pontine nuclei and lateral 
reticular nucleus, regions of high 6 mRNA expression, 
suggesting a S receptor circuit. The dorsal lateral geniculate 
nucleus of the thalamus, which receives primary visual 
projections from the retina and provides the main afferent 
projections to the visual cortex (Ribak and Peters, 1975), 
expresses predominantly p mRNA, whereas the cells in 
ventral lateral geniculate express both p and K and may be 
involved in brightness discrimination (Legg and Cowey, 
1977). Cells expressing p, 6 ,  and K mRNAs are also localized 
in specific laminae of the visual cortex, where they may play 
a role in visual discrimination. Cells of the claustrum, 
which express high levels of S and K but low levels of p 
mRNA, project to the visual cortex (LeVay and Sherk, 
1981), potentially influencing the processing of visual infor- 
mation. 
In the auditory system, the cochlear and trapezoid nuclei, 
regions of primary and secondary auditory processing, 
express predominantly S receptor mRNA, with moderate 
levels of K mRNA expression in the cochlear nucleus. 
However, higher sites of auditory processing such as the 
superior olivary complex, the nuclei of the lateral lemniscus 
and medial geniculate bodies express predominantly p 
receptor mRNA. In the inferior colliculus, cells expressing p 
and 6 receptor mRNAs are localized in the dorsal, central, 
and external cortex, whereas those expressing K are local- 
ized only in the dorsal and external cortex. Taken together, 
the results suggest that 6 and K receptors may be involved 
in the primary processing of auditory information, whereas 
p receptors may be involved in further integration of the 
information prior to relaying it to the auditory cortex. 
In the somatosensory systems, cells expressing opioid 
receptor mRNAs are observed in the dorsal root ganglia, 
dorsal horn of the spinal cord, nucleus gracilis and cunea- 
tus, sensory and spinal trigeminal, ventromedial, posterior 
and intralaminar nuclei of the thalamus, and the parietal 
cortex. The opioid receptor mRNAs are differentially ex- 
pressed in the dorsal root ganglia, with p receptor mRNA 
localized in medium-sized and large cells, K in smaller 
diameter neurons, and S in predominantly large-diameter 
cells. This differential distribution may be related to the 
differential processing of thermoceptive, mechanoceptive, 
and nociceptive responses mediated by these neurons. 
Concordant with this suggestion, opioid analgesics vary 
in their effectiveness depending on type and intensity 
of nociceptive stimulus used and receptor type activated 
(Schmauss and Yaksh, 1984; Millan, 1986, 1990). K-Selec- 
tive analgesics are effective in modulating visceral and 
low-intensity thermal and mechanical nociceptive re- 
sponses, whereas 6 analgesics are potent in inhibiting a 
range of thermal and mechanical stimuli and are relatively 
ineffective in inhibiting visceral nociception. p Analgesics 
have a broader range of action on thermal, mechanical, and 
visceral stimuli that might be related to the larger number 
of medium- and large-diameter dorsal root ganglia neurons 
that express p receptor mRNA. Although cell diameter is a 
discriminating feature in DRG neurons, colocalization stud- 
ies with neuropeptides such as somatostatin, enkephalin, 
substance P, and dynorphin are needed to characterize 
these cells properly. 
Afferent fibers from cells in the DRG send collaterals that 
synapse in the dorsal horn of the spinal cord, where p-, 6-, 
and K-expressing cells are observed, and the nucleus gracilis 
and cuneatus, where cells expressing p receptor mRNA 
predominate. This, in addition to the high levels of 
receptor mRNA expression observed in the posterior, ven- 
tromedial, and intralaminar nuclei of the thalamus, sug- 
gests that p receptors may regulate much of the somatosen- 
sory information received from the body. The 6 and K 
mRNA expression observed in the spinal and sensory 
trigeminal nuclei, however, argues that these sites may be 
more involved in receiving and processing information from 
the face and nasal mucosa as well as in higher order 
processing in the somatosensory cortex. 
In addition to directly inhibiting sensory afferents enter- 
ing the spinal cord, opioid analgesics produce their effects 
by modulating descending pain-inhibitory pathways origi- 
nating in the midbrain and brainstem (Fields and Bas- 
baum, 1978; Yaksh and Rudy, 1978). The central gray, the 
midline raphe nuclei, and the mesencephalic and gigantocel- 
lular reticular nuclei, which have been implicated in these 
pathways, are regions of p, 6, and K receptor mRNA 
expression. Although there is agreement that p analgesics 
produce their effects at both supraspinal and spinal sites of 
actions, much debate surrounds 6 and K analgesics; some 
have argued for an exclusively spinal site of action (Piercy 
et al., 1982; Kaneko et al., 1983; Fang et al., 1986). The 
anatomical findings of predominantly IJ. and K mRNA 
expression in the central gray and raphe nuclei and p, 6, 
and K expression in the mesencephalic and gigantocellular 
reticular nuclei support the view that p, 6 ,  and K agonists 
can produce their effects at  both the supraspinal and the 
spinal levels (Porreca et al., 1987; Millan et al., 1989). 
Opioid agonists, in addition to being potent analgesics, 
produce significant effects on respiratory, cardiovascular, 
and gastrointestinal functions (Pfeiffer et al., 1983a; Por- 
reca et al., 1984; Fox and Burks, 1988; Kiritsy-Roy et al., 
1989). Many of these effects are likely coordinated by the 
nucleus of the solitary tract (Carter and Lightman, 1985; 
Rhim et al., 1993), nucleus ambiguus, and dorsal motor 
nucleus of vagus, regions that express predominantly p 
and/or K receptor mRNA. The caudal portion of the nucleus 
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of the solitary tract, which has been implicated in cardiovas- 
cular function, contains predominantly K, with some p, 
mRNA expression, whereas the rostra1 portion, which has 
been associated with gustatory functions, contains predomi- 
nantly cells expressing p receptor mRNA. The paratrigemi- 
nal, which receives visceral input from the nasal mucosa, 
expresses exclusively K receptor mRNA. These anatomical 
findings suggest that predominantly p. and K receptors 
mediate the cardiovascular, respiratory, and gastrointesti- 
nal responses observed with opioid administration. 
Among the better characterized effects of opioid agonists 
are their actions on hormonal release. Several studies 
(Pang et al., 1977; Slizgi and Ludens, 1982; Pfieffer et al., 
1983b, 1985; Carter and Lightman, 1984; Bicknell et al., 
1985; Krulich et al., 1986; Laedem and Yagenova, 1987; 
Iyengar et al., 1987; Manzanares et al., 1990) have demon- 
strated that opioid agonists increase the release of prolactin 
(PRL), growth hormone (GH), proopiomelanocortin pep- 
tides (POMC), and corticosteroids (CORT), while decreas- 
ing the release of luteinizing hormone (LH), OXY, and AVP. 
The relative involvement of the specific receptor types in 
these hormonal effects and the anatomical site of action is, 
however, less clear. Most of the inconsistencies observed 
surround the involvement of 6 receptors, with some studies 
demonstrating S receptor-mediated effects on PRL, POMC, 
and LH secretion and others reporting no effect (Pfeiffer et  
al., 1983b; Wiesner et al., 1985; Iyengar et al., 1987; 
Leadem and Yagenova, 1987; Kehoe et al., 1993). Such 
inconsistencies are likely due to a previous lack of S-selec- 
tive agonists, which may have confused the interpretation 
of the results. In addition, the relatively low levels of S 
receptor binding and mRNA expression observed in the 
neuroendocrine systems mediating these effects suggest 
that S receptors may play a minor role. p And K agonists 
similarly increase PRL, POMC, and CORT and decrease 
LH, suggesting a wide range of actions on both hypotha- 
lamic-pituitary-gonadal as well as adrenal axes. The inhibi- 
tion of OXY and AVP is selective for K receptor agonists 
(Carter and Lightman, 1984; Bicknell et  al., 1985; Leander 
et al., 1985,1987), suggesting a specific role of K receptors in 
lactation, uterine contraction, and water balance. Some 
studies report an inhibition of AVP and OXY release with p. 
agonists (Van de Heijning et al., 1991). 
The hormonal effects described above demonstrate that 
opioid peptides can modulate the release of hormones from 
the anterior (ACTH, PRL, GH, LH), intermediate (a- 
melanocyte-stimulating hormone; a-MSH), and neural 
(OXY, AVP) lobes of the pituitary. The anterior and 
intermediate lobes of the pituitary are not, however, the 
primary sites of action; agonists fail to affect hormonal 
release in pituitary cultures (Buckingham, 19821, and 
receptor autoradiographic studies have localized only K 
binding sites in the neural lobe, with no p. or 6 binding 
observed in the other lobes of the pituitary (Herkenham, 
1986). The focus has, therefore, shifted to the cells of the 
hypothalamus that project to the median eminence and 
influence the release of anterior pituitary hormones to 
explain the p receptor-mediated effects (Wiesner et al., 
1984; Kapoor and Willoughby, 1990). For example, p. and K 
expression in the medial preoptic area and p. expression in 
the medial preoptic nucleus, where high numbers of lutein- 
izing hormone-releasing hormone (LHRH) neurons are 
localized (for review, see Swanson, 19871, suggest that 
these regions may be important in opioid-mediated inhibi- 
tion of LH secretion. Localization of cells expressing p and K 
mRNAs in the parvocellular paraventricular hypothalamic 
nucleus suggests a possible colocalization with CRH and 
may be related to the increased release of corticosteroids 
following opioid administration. Opioid mediation of prolac- 
tin and a-MSH release, which are dependent on tuberoinfun- 
dibular and tuberohypophysial dopamine, respectively, may 
be regulated by p a n d  K-expressing cells in the arcuate 
nucleus (Manzanares et al., 1990, 1992). Similarly, the 
localization of p-endorphin and growth hormone-releasing 
factor in the cells of the arcuate nucleus suggests that this 
may be the site of action of p- and K-mediated effects on 
corticosteroids and GH. Corticosteroid levels may be influ- 
enced by p-endorphin neurons projecting to the median 
eminence to affect the pituitary directly or via their projec- 
tions to the paraventricular nucleus. Colocalization studies 
examining the distribution of the opioid receptor mRNAs in 
relation to the hypothalamic releasing hormones as well as 
microinjection of specific opioid agonists in selective nuclei 
are clearly necessary to verify these suggestions. 
Although we have emphasized potential hypothalamic 
nuclei in mediating these opioid-hormone effects, other 
regions in the CNS, particularly in the midbrain and 
brainstem, that project to the hypothalamus likely play 
critical roles. The nucleus of the solitary tract and parabra- 
chial nucleus, which project to paraventricular hypotha- 
lamic and arcuate nuclei, for example, may be important 
sites of hormonal regulation by p agonists, especially given 
the comparatively low levels of p receptor mRNA expres- 
sion found in the hypothalamic nuclei. 
The localization of cells in the median eminence and 
infundibulum that exclusively express K receptor mRNA 
and binding (Mansour et al., 1987) suggests that K agonists, 
unlike p, may regulate hormone release by their action on 
cell terminals at  the level of the median eminence in 
addition to modulating activity of hypothalamic neurons. 
The identification of ependymal cells as well as neurons in 
the median eminence suggests that these cells may monitor 
levels of opioid peptides in the cerebrospinal fluid (CSF) to 
regulate subsequent release. Colocalization studies with 
glial-and neuronal-specific markers are necessary to charac- 
terize the K receptor-expressing cells in the median emi- 
nence and infundibular stem. A few scattered neurons 
expressing P-endorphin have been identified in the median 
eminence (Ishikawa et al., 1992), and it will be interesting 
to see if they also express K receptors. 
Conflicting results have emerged with regard to the site 
of action of K agonists on OXY and AVP release. Some 
studies using isolated terminals from rat neural lobe sug- 
gest that K receptors are localized on oxytocin terminals and 
not vasopressin (Falke and Martin, 1988), whereas others 
demonstrate that K receptors are on both OXY and AVP 
terminals and are able to inhibit the release of both 
neurophysins (Zhao et al., 1988). The failure to detect cells 
expressing K receptor mRNA in the neural lobe (Mansour et 
al., 1994a) and the high levels of K receptor mRNA in the 
magnocellular paraventricular and supraoptic nuclei sug- 
gest that the K receptor binding sites are synthesized in 
these hypothalamic nuclei and are transported to terminals 
in the neural lobe. Colocalization studies in the paraventricu- 
lar and supraoptic nuclei are, however, necessary to deter- 
mine whether there is a preferential localization with OXY 
or AVP. 
Opioid receptors have been implicated in the control of 
feeding behavior (Morley and Levine, 1983; Leibowitz, 
1985; Gosnell et al., 1986, 1987; Cooper et al., 1988). 
Generally, p and K agonists such as morphine, DAMGO, 
and U50,488 produce an increase in feeding, whereas opiate 
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antagonists reduce food intake. The majority of studies 
support a p and K receptor involvement in feeding, although 
some studies suggest that 6 receptors may also be involved 
(Bakshi and Kelly, 1993). The localization of cells express- 
ing p and K receptor mRNAs in the gustatory-related nuclei 
of the CNS, including the nucleus of the solitary tract, 
parabrachial nucleus, bed nucleus stria terminalis, central 
amygdala, and lateral and paraventricular hypothalamus, 
is supportive of a broad role of p and K receptors in 
maintaining feeding behavior. The findings that p and 6 
agonists can elicit a feeding response in the nucleus accum- 
bens (Bakshi and Kelly, 1993) suggest that this site may be 
involved in the rewarding properties of food. On the other 
hand, the high levels of 6 and K receptor mRNA expression 
in the ventromedial nucleus of the hypothalamus suggest 
that these receptor types may be important in long-term 
food intake and satiety. In that feeding is a complex 
behavior, it is not surprising that all three opioid receptor 
types may be differentially involved depending on the site of 
injection, the neural system activated, and the physiological 
state of the animal. 
In contrast to most opiate-mediated behaviors, opioid 
agonists produced markedly different effects on locomotion. 
At low doses, p and 6 agonists produce an increase in gross 
motor activity, although, at  high doses, p agonists produce 
catalepsy and profound muscular rigidity in the rat (Iwa- 
mot0 et  al., 1981). K Agonists, on the other hand, fail to 
produce an increase in locomotion at any dose and have 
predominantly sedative effects (Martin et al., 1976). These 
behavioral differences in response to opioids have been 
associated with a differential release of nigrostriatal dopa- 
mine, with p and 6 agonists increasing, and K agonists 
decreasing, striatal dopamine release (Mulder et al., 1984; 
Di Chiara and Imperato, 1988). The distribution of opioid 
binding sites and receptor mRNAs in the nigrostriatal 
system suggests that the opioid receptors may be differen- 
tially localized within the nigrostriatal loop, in part explain- 
ing these effects on dopamine release. The high levels of K 
mRNA expression in the substantia nigra, pars compacta, 
in conjunction with little K receptor binding (Mansour et al., 
1987; 1994a), suggest that these sites are synthesized in the 
pars compacta and are transported to presynaptic termi- 
nals, where they may directly affect dopaminergic release. 
On the other hand, the presence of p receptor binding sites 
in the substantia nigra, pars reticulata, with few cells 
expressing p receptor mRNA, suggests that these binding 
sites are on terminals originating, at least in part, in the 
striatum. Given that p agonists iontophoretically applied to 
the substantia nigra, pars compacta, fail to affect dopamin- 
ergic cell firing (Hommer and Pert, 19831, the increase in 
dopamine release following systemic p agonists is likely 
indirect. The anatomical data suggest that p receptors 
localized in striatal cells bodies that project to the dopamin- 
ergic cells of the substantia nigra may mediate the increase 
in dopamine release and the observed increase in locomo- 
tion with p agonists. The presence of 6 receptor mRNA and 
binding in the substantia nigra, pars reticulata, suggests a 
local synthesis of 6 receptors and an indirect modulation of 
dopamine release via inhibition of an inhibitory interneu- 
ron (Collingridge and Davies, 1982; Hommer and Pert, 
1983). The visualization of K binding sites and mRNA in the 
substantia nigra, pars reticulata, similarly suggests a local 
synthesis; however, these receptors are localized in a popu- 
lation of cells different from those that express 6. This is 
supported by the finding that intranigral injections of K 
agonists produce circling that is independent of dopamine 
systems, whereas circling induced by 6 agonists requires 
intact dopamine neurons (Matsumoto et al., 1988). 
Opposing effects of opioids are also observed with regard 
to their positive reinforcing or hedonic properties. p. And 6 
agonists generally act as reinforcers, being self-adminis- 
tered into specific brain areas and positively associated in 
conditioned place-preference paradigms (Bozarth and Wise, 
1981, 1984; Shippenberg et al., 1987). K Agonists, on the 
other hand, are aversive, reportedly producing dysphoria in 
humans (Pfeifer et  al., 1986) and conditioned place aversion 
in rats in paired-drug paradigms (Bals-Kubik et  al., 1989). 
These behavioral differences have been linked to the effects 
of opioid agonists on mesolimbic dopamine systems, with p 
and 6 agonists stimulating release of dopamine in the 
nucleus accumbens and K agonists decreasing release, paral- 
leling the effects observed in the nigrostriatal system (Di 
Chiara and Imperato, 1988). Recent electrophysiological 
studies (e.g., Johnson and North, 1992) have generally been 
supportive of this position, demonstrating that p agonists 
hyperpolarize dopamine neurons in the ventral tegmental 
area indirectly via a secondary GABAergic interneuron. 
Cells expressing p receptor mRNA were detected in the 
ventral tegmental area in the present study and, given 
these electrophysiological results, may be localized on GABA 
neurons. Because it is difficult to compare these anatomical 
findings directly to the electrophysiological findings pre- 
sented above, colocalization studies of the opioid receptor 
and GABA mRNAs are necessary to confirm these observa- 
tions. 
In addition to gross motor movements, the localization of 
opioid receptor mRNAs in brainstem motor nuclei that 
innervate the head and tongue suggests that opioid recep- 
tors mediate a broad range of motor functions. The selec- 
tive expression of 6 receptor mRNA in the hypoglossal 
nucleus and p receptor in the nucleus ambiguus, for 
example, suggests that both of these receptors may be 
important in controlling tongue movements. Similarly, the 
high levels of 6 receptor mRNA expression and lower levels 
of K and p expression in the motor trigeminal nucleus 
suggest that predominantly 6 receptors may be involved in 
controlling the muscles of mastication. A further role of p 
and 6 receptors in modulating motor responses is suggested 
by a localization of p and 6 receptor mRNAs in the 
oculomotor nucleus and the ventral horn of the spinal cord. 
Detection of 6 receptor mRNA in the lobules of the 
cerebellum is somewhat surprising given the lack of specific 
6 receptor binding. This may reflect a dissociation of 
transcriptional and translational control of 6 receptors in 
the cerebellum, so, although the mRNA is present, it is not 
effectively translated into a functional binding protein. 
Alternatively, the relatively high levels of nonspecific bind- 
ing observed with selective 6 ligands, such as DPDPE, may 
not allow the detection of low levels of 6 receptor binding. 
I t  is tempting to speculate that, given the levels of 6 
receptor mRNA expression in all cortical regions, the 
pontine nuclei, red nucleus, lateral reticular nucleus, cerebel- 
lum, and spinal cord, a primary function of 6 receptors may 
be that of sensory-motor integration. Much of the somato- 
sensory motor, visual, and auditory cortices project to the 
pontine nuclei, which, in turn, project to the cerebellum, 
which is in the position to influence descending pathways. 
This pathway, in addition to the corticospinal, corticorubro- 
spinal, and the reticulocerebellar pathways, provides the 
major connections between cortical areas and either the 
cerebellum or the spinal cord. These pathways are impor- 
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tant in initiating voluntary movements and may represent 
specific 6 receptor circuits. 
In conclusion, this study provides the first comparative 
analysis of the IJ., 6, and K receptor mRNA distributions in 
the CNS. It lays the foundation for future tract-tracing, 
colocalization, and regulatory studies that will further 
define the specific circuits and functions mediated by the 
opioid receptors. These studies in combination with those 
designed to visualize the opioid peptides will provide insight 
into the organization of the opioid systems and a better 
understanding of the opioid receptors with which they 
interact. 
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